Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
- NCT ID
- NCT07728318
- Registry status
- Not yet recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- Akhtar Saeed Medical and Dental College
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Enrollment: 52 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
1. Male and female patients aged 30 to 80 years with diagnosed Type 2 Diabetes Mellitus.
2. Uncontrolled diabetes with HbA1c ≥ 7.0%.
3. Obesity defined as Body Mass Index (BMI) ≥ 25 kg/m² (Asian population threshold) or waist circumference \> 90 cm in men or \> 80 cm in women.
4. History of taking oral antidiabetic drugs (OADs) for \> 1 year.
Exclusion Criteria:
1. Patients currently or previously taking GLP-1 receptor agonists or weight loss medications.
2. Patients currently receiving insulin therapy.
3. Patients taking DPP-4 inhibitors.
4. Pregnant or lactating females.
Study locations
No study locations are listed in the registry data.
Study details
- Start date
- August 12, 2026
- Primary completion date
- January 12, 2027
- First posted
- July 27, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07728318
- Registry last updated
- September 14, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07728318 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ